v3.26.1
Organization and Nature of Operations (Details) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Oct. 31, 2024
Dec. 31, 2023
Organization and Nature of Operations [Line Items]        
Net loss $ (2,236,433) $ (3,016,884)    
Net cash used in operating activities (644,842) (660,302)    
Accumulated deficit (9,495,799) (7,259,366)    
Stockholders’ deficit (4,388,206) $ (2,378,145)   $ (1,461,565)
Working capital deficit 4,397,372      
Cash on hand $ 1,252      
Precision Genomics, Inc. [Member]        
Organization and Nature of Operations [Line Items]        
Subsidiary, Ownership Percentage, Parent     100.00%  
Exousia Ai, Inc.[Member]        
Organization and Nature of Operations [Line Items]        
Subsidiary, Ownership Percentage, Parent 100.00% 100.00%